非ST段抬高型急性冠状动脉综合征基层合理用药指南

2021-04-06 中华医学会临床药学分会 中华全科医师杂志

NSTE-ACS根据心肌损伤生物标志物测定结果分为非ST段抬高型心肌梗死和不稳定性心绞痛。

中文标题:

非ST段抬高型急性冠状动脉综合征基层合理用药指南

发布日期:

2021-04-06

简要介绍:

非ST段抬高型急性冠状动脉综合征(non-ST-segment elevation acute coronary syndrome,NSTE-ACS)根据心肌损伤生物标志物[主要为心脏肌钙蛋白(cardiac troponin,cTn)]测定结果分为非ST段抬高型心肌梗死(non-ST-segment elevation myocardial infarction,NSTEMI)和不稳定性心绞痛(unstable angina,UA),后者包括静息型心绞痛、初发型心绞痛、恶化型心绞痛和变异型心绞痛。

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1185606, encodeId=9ee61185606ad, content=学习了<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Tue Jan 18 13:27:35 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079372, encodeId=64be10e9372ad, content=学习了,很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 13 00:31:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016166, encodeId=7dd71016166a2, content=z, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/15e0ee88dd1845bb9b002d8164e47910/b8fcb588206b48e89fa686d0ccc1325a.jpg, createdBy=b8df5528129, createdName=蔡文姬没有文, createdTime=Thu Sep 09 22:07:36 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1185606, encodeId=9ee61185606ad, content=学习了<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Tue Jan 18 13:27:35 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079372, encodeId=64be10e9372ad, content=学习了,很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 13 00:31:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016166, encodeId=7dd71016166a2, content=z, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/15e0ee88dd1845bb9b002d8164e47910/b8fcb588206b48e89fa686d0ccc1325a.jpg, createdBy=b8df5528129, createdName=蔡文姬没有文, createdTime=Thu Sep 09 22:07:36 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2021-12-13 ms6000000225486324

    学习了,很有收获

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1185606, encodeId=9ee61185606ad, content=学习了<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Tue Jan 18 13:27:35 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079372, encodeId=64be10e9372ad, content=学习了,很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 13 00:31:15 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016166, encodeId=7dd71016166a2, content=z, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210618/15e0ee88dd1845bb9b002d8164e47910/b8fcb588206b48e89fa686d0ccc1325a.jpg, createdBy=b8df5528129, createdName=蔡文姬没有文, createdTime=Thu Sep 09 22:07:36 CST 2021, time=2021-09-09, status=1, ipAttribution=)]
    2021-09-09 蔡文姬没有文

    z

    0